Effect of the Initial Regimen on the Rate of Specific Mutations Even among different HAART regimens, the selection of the initial regimen also has important implications in terms of selecting for ...

ViiV Healthcare’s Dovato has been approved for use in the US and EU since 2019, but its sales remain overshadowed by Gilead’s Biktarvy.

High prevalence of pretreatment and acquired drug resistance in children with HIV, especially in sub-Saharan Africa, was identified. Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are a ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced ...

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with drug-resistant infections in 2022. While there is still no vaccine for the ...

Individuals with HIV who were resistant to all four antiretroviral drug classes experienced higher mortality than those who were not resistant, a difference primarily due to lower CD4 cell counts.

The difference between regimens met the trial's noninferiority threshold ...

(Kateryna Kon/Science Photo Library/Getty Images) Scientists have just announced the results from the first clinical trial in ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...

ST Pharm has confirmed the antiviral efficacy of its independently developed oral candidate drug for Human Immunodeficiency ...